These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4198288)

  • 1. Mechanisms of drug-enzyme interactions.
    Handschumacher RE; Hare LE
    Anesthesiology; 1973 Aug; 39(2):165-77. PubMed ID: 4198288
    [No Abstract]   [Full Text] [Related]  

  • 2. Conformational adaptability in enzymes.
    Citri N
    Adv Enzymol Relat Areas Mol Biol; 1973; 37():397-648. PubMed ID: 4632894
    [No Abstract]   [Full Text] [Related]  

  • 3. Searching for new allosteric sites in enzymes.
    Hardy JA; Wells JA
    Curr Opin Struct Biol; 2004 Dec; 14(6):706-15. PubMed ID: 15582395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug distribution and effect.
    Curry SH
    J R Coll Physicians Lond; 1970 Jul; 4(4):315-34. PubMed ID: 4948351
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary: The receptor concept in evolution.
    Ariëns EJ; Beld AJ
    Biochem Pharmacol; 1977 May; 26(10):913-8. PubMed ID: 324474
    [No Abstract]   [Full Text] [Related]  

  • 6. [Structure and function of enzymes].
    Brand K
    Z Ernahrungswiss Suppl; 1969; 8():5-32. PubMed ID: 5004260
    [No Abstract]   [Full Text] [Related]  

  • 7. Computer modelling of enzyme catalysed reaction mechanisms.
    Mulholland AJ; Grant GH; Richards WG
    Protein Eng; 1993 Feb; 6(2):133-47. PubMed ID: 8475041
    [No Abstract]   [Full Text] [Related]  

  • 8. Sensitivity amplification in biochemical systems.
    Goldbeter A; Koshland DE
    Q Rev Biophys; 1982 Aug; 15(3):555-91. PubMed ID: 6294720
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for positive allosteric modulators of biological targets.
    Groebe DR
    Drug Discov Today; 2006 Jul; 11(13-14):632-9. PubMed ID: 16793532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [General pharmacodynamic principles].
    Bernard JP; Opdal MS; Khiabani H
    Tidsskr Nor Laegeforen; 2006 Aug; 126(16):2107-9. PubMed ID: 16932780
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation and use of cloned, expressed human drug-metabolizing enzymes in heterologous cells for analysis of drug metabolism and drug-drug interactions.
    Remmel RP; Burchell B
    Biochem Pharmacol; 1993 Aug; 46(4):559-66. PubMed ID: 8363629
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemistry and enzymology of kcat inhibitors.
    Rando RR
    Science; 1974 Jul; 185(4148):320-4. PubMed ID: 4209261
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible mechanisms of enzyme inhibition and resulting clinical significance.
    Ring B; Wrighton SA; Mohutsky M
    Methods Mol Biol; 2014; 1113():37-56. PubMed ID: 24523108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of drug enantiomers in clinical pharmacology.
    Williams K; Lee E
    Drugs; 1985 Oct; 30(4):333-54. PubMed ID: 3905334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Side effects of drugs].
    Chekhman IS; Zagorodnia IS
    Farm Zh; 1976; 31(1):9-17. PubMed ID: 773677
    [No Abstract]   [Full Text] [Related]  

  • 16. Subunit interactions in enzyme catalysis. Kinetic models for one-substrate polymeric enzymes.
    Ricard J; Mouttet C; Nari J
    Eur J Biochem; 1974 Feb; 41(3):479-97. PubMed ID: 4817559
    [No Abstract]   [Full Text] [Related]  

  • 17. Does the coupling between conformational fluctuation and enzyme catalysis involve a true phase transfer catalysis?
    Olavarría JM
    J Theor Biol; 1982 Nov; 99(1):21-30. PubMed ID: 7169796
    [No Abstract]   [Full Text] [Related]  

  • 18. Some aspects of drug action: a comparison with intramolecular processes occurring in pharmaceutical and biochemical systems.
    Smith HJ; Williams H
    J Pharm Pharmacol; 1965 Oct; 17(10):601-18. PubMed ID: 4379684
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical importance of pharmacokinetic and pharmacodynamic drug interactions.
    Koch-Weser J
    Neth J Med; 1977; 20(2):59-70. PubMed ID: 325426
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the pharmacokinetics of chemotherapeutic agents: competitive phenomena].
    Dettli L
    Verh Dtsch Ges Inn Med; 1968; 74():816-21. PubMed ID: 5714427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.